We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
176
Relay Therapeutics
RLAY
$4.06B
$18.5M 0.12%
1,238,872
+79,451
+7% +$1.52M
CHGG icon
177
Chegg
CHGG
$110M
$18.5M 0.12%
731,323
-313,134
-30% -$7.96M
MDB icon
178
MongoDB
MDB
$24.9B
$18.5M 0.12%
93,782
+39,702
+73% +$7.07M
XNCR icon
179
Xencor
XNCR
$1.47B
$18.4M 0.12%
707,368
-28,153
-4% -$787K
BSX icon
180
Boston Scientific
BSX
$67.6B
$18.3M 0.12%
395,878
-43,458
-10% -$1.88M
ARVN icon
181
Arvinas
ARVN
$530M
$18.3M 0.12%
534,002
+14,710
+3% +$619K
PDD icon
182
Pinduoduo
PDD
$121B
$18.3M 0.12%
224,000
+164,000
+273% +$11.4M
ULTA icon
183
Ulta Beauty
ULTA
$20.7B
$18.1M 0.12%
38,495
+27,461
+249% +$11.8M
REPL icon
184
Replimune Group
REPL
$724M
$18M 0.12%
662,922
+53,350
+9% +$1.11M
META icon
185
Meta Platforms (Facebook)
META
$1.51T
$17.8M 0.12%
148,204
-4,544
-3% -$534K
ZBRA icon
186
Zebra Technologies
ZBRA
$12.6B
$17.6M 0.12%
68,831
+11,981
+21% +$3.1M
IONS icon
187
Ionis Pharmaceuticals
IONS
$9.25B
$17.6M 0.12%
465,700
+14,349
+3% +$604K
ALB icon
188
Albemarle
ALB
$13.7B
$17.5M 0.12%
80,662
+46,035
+133% +$12.3M
RVMD icon
189
Revolution Medicines
RVMD
$40B
$17.4M 0.12%
732,505
– –
JEF icon
190
Jefferies Financial Group
JEF
$13B
$17.3M 0.12%
526,885
+94,714
+22% +$3.15M
CI icon
191
Cigna
CI
$77B
$16.7M 0.11%
50,312
-8,005
-14% -$2.53M
COST icon
192
Costco
COST
$422B
$16.3M 0.11%
35,604
+3,387
+11% +$1.66M
KRTX
193
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$16.2M 0.11%
82,201
– –
RNR icon
194
RenaissanceRe
RNR
$13.7B
$15.9M 0.11%
86,505
-30,275
-26% -$5.1M
GPK icon
195
Graphic Packaging
GPK
$3.3B
$15.9M 0.11%
715,007
+134,191
+23% +$2.95M
MRSN
196
DELISTED
Mersana Therapeutics
MRSN
$15.8M 0.11%
107,714
+7,800
+8% +$1.32M
OI icon
197
O-I Glass
OI
$1.41B
$15.7M 0.11%
944,602
-390,166
-29% -$6.28M
AMRC icon
198
Ameresco
AMRC
$1.12B
$15.7M 0.11%
273,916
+43,628
+19% +$2.66M
MSCI icon
199
MSCI
MSCI
$41.5B
$15.2M 0.1%
32,672
-6,247
-16% -$2.91M
VEEV icon
200
Veeva Systems
VEEV
$31.6B
$15M 0.1%
92,872
+54,795
+144% +$9.36M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.